Philips resolved the Respironics litigation, settling for $1.1 billion. And Exor decided to boost its stake in the company. Supportive shareholders' remuneration is linked to Exor's portfolio results, ...

Exor’s FY24 performance was uninspiring, with Stellantis dragging down the very strong contribution from Ferrari. Recent actions—reducing Ferrari concentration, executing a large buyback, and ...

The Tender Offer will be carried out as part of the €1 billion share buyback program announced by Exor in February 2025. Exor's Board of Directors believes that the current value of Exor provides an ...

Shares sold at 450 euros each, bookrunner says Ferrari bought back 300 million euros of its own shares Exor will retain 20% stake, 30% voting rights in Ferrari The sale will help Exor reduce ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. John Elkann, scion of Italy’s Agnelli dynasty, has said its €2.6bn investment in Dutch conglomerate Philips was ...